Clin Sarcoma Res. 2016 Jul 11;6:11. doi: 10.1186/s13569-016-0052-4. eCollection 2016.
Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services.
Clinical sarcoma research
Susie Bae, Philip Crowe, Raghu Gowda, Warren Joubert, Richard Carey-Smith, Paul Stalley, Jayesh Desai
Affiliations
Affiliations
- Department of Medical Oncology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, VIC 3002 Australia.
- Department of Surgery, Prince of Wales Hospital, Barker St, Randwick, NSW 2031 Australia.
- Department of Radiation Oncology, Royal Adelaide Hospital, North Terrace, Adelaide, SA 5000 Australia.
- Department of Medical Oncology, Princess Alexandra Hospital, 199 Ipswich Rd, Woolloongabba, QLD 4102 Australia.
- Department of Orthopaedic Surgery, Sir Charles Gardner Hospital, Hospital Ave, Nedlands, WA 6009 Australia.
- Department of Orthopaedic Surgery, Royal Prince Alfred Hospital, Missenden Rd, Camperdown, NSW 2050 Australia.
PMID: 27403280
PMCID: PMC4939824 DOI: 10.1186/s13569-016-0052-4
Abstract
BACKGROUND: There is a paucity of data on the current management of patients with advanced soft tissue sarcoma (STS) in the Australian health care setting. This study utilised the Australian sarcoma database to evaluate the patterns of care delivered to patients with advanced STS at Australian sarcoma services.
METHODS: Prospectively collected data from six sarcoma centres in Australia were sourced to identify patients diagnosed with advanced STS between 1 January 2010 and 31 December 2012. Descriptive statistics were analysed for patient demographics, clinicopathological characteristics and treatment patterns. Overall survival was estimated using the Kaplan-Meier product limit method.
RESULTS: Of 253 patients with advanced STS, four major STS subtypes were identified: undifferentiated pleomorphic sarcoma (23 %), leiomyosarcoma (17 %), liposarcoma (14 %), and synovial sarcoma (8 %); with the rest grouped as "other STS" (38 %). Approximately one-third of patients received palliative systemic therapy with the most common first-line therapy being doxorubicin alone (50 %). A small percentage of patients participated in clinical trials (20 %). Palliative radiotherapy was utilised mostly for treatment of symptomatic distant metastases and one-third of patients underwent metastasectomy, most commonly for pulmonary metastases. The median overall survival (OS) in this series was 18 months and no significant difference in OS was observed across different STS histological subtypes.
CONCLUSIONS: This is the first detailed study outlining patterns of care for Australian patients with advanced STS managed at sarcoma services. These data highlight a particular area of weakness in the lack of clinical trials for sarcoma patients and also serve as an important reference point for understanding how practice may change over time as treatment options evolve.
Keywords: Advanced soft tissue sarcoma; Chemotherapy; Metastasectomy; Metastatic sarcoma; Palliative-intent treatment; Patterns of care study; Radiotherapy
References
- Pathology. 2014 Feb;46(2):160-3 - PubMed
- CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300 - PubMed
- J Clin Oncol. 1999 Jan;17(1):150-7 - PubMed
- J Clin Oncol. 1993 Jul;11(7):1276-85 - PubMed
- J Clin Oncol. 1987 Jun;5(6):840-50 - PubMed
- Lancet Oncol. 2007 Jul;8(7):595-602 - PubMed
- Cancer. 2008 Apr 1;112(7):1585-91 - PubMed
- Ann Oncol. 2005 Mar;16(3):437-44 - PubMed
- Ann Oncol. 2012 Oct;23(10):2763-70 - PubMed
- Cancer. 1994 May 15;73(10):2506-11 - PubMed
- BMC Cancer. 2015 Mar 25;15:175 - PubMed
- Lancet Oncol. 2014 Apr;15(4):415-23 - PubMed
- J Clin Oncol. 2008 Nov 10;26(32):5269-74 - PubMed
- Am J Clin Oncol. 1998 Jun;21(3):317-21 - PubMed
- Ann Oncol. 2012 Oct;23 Suppl 7:vii92-9 - PubMed
- J Clin Oncol. 1993 Jul;11(7):1269-75 - PubMed
- Cancer. 1999 Nov 15;86(10):2034-7 - PubMed
- J Clin Oncol. 2002 Jun 15;20(12):2824-31 - PubMed
Publication Types